CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Phenotypic and spatial heterogeneity of CD8(+) tumour infiltrating lymphocytes.
Phenotypic and spatial heterogeneity of CD8(+) tumour infiltrating lymphocytes.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
CD8+ T细胞是执行适应性抗肿瘤反应的主力,也是多种癌症免疫治疗的靶点。最新进展揭示了CD8+TIL(肿瘤浸润淋巴细胞)的巨大异质性,并越来越清楚地表明,内源性和治疗诱导的肿瘤抑制势能主要依赖于具有优势属性的特定CD8+ T细胞亚群,即记忆和干细胞样耗竭亚群。本文对当前关于癌症中CD8+ T细胞的认知、相关兴趣亚群以及决定其浸润构型因素进行了审视,这可为未来进一步探究其分化和迁移背后的调控网络,并据此优化基于T细胞的免疫治疗奠定基础。
CD8 + T cells are the workhorses executing adaptive anti-tumour response, and targets of various cancer immunotherapies. Latest advances have unearthed the sheer heterogeneity of CD8 + tumour infiltrating lymphocytes, and made it increasingly clear that the bulk of the endogenous and therapeutically induced tumour-suppressive momentum hinges on a particular selection of CD8 + T cells with advantageous attributes, namely the memory and stem-like exhausted subsets.
A scrutiny of the contemporary perception of CD8 + T cells in cancer and the subgroups of interest along with the factors arbitrating their infiltration contextures, presented herein, may serve as the groundwork for future endeavours to probe further into the regulatory networks underlying their differentiation and migration, and optimise T cell-based immunotherapies accordingly.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。